Skip to content

COBRA: Cancer, Older Adults, Balance and Resistance Activities

COBRA: Cancer, Older Adults, Balance and Resistance Activities

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07011862
Enrollment
38
Registered
2025-06-10
Start date
2025-05-30
Completion date
2027-05-30
Last updated
2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Metastatic Cancer, Primary Cancer

Keywords

Primary Cancer, Metastatic Cancer, Cancer, 25-090, Memorial Sloan Kettering Cancer Center

Brief summary

The purpose of this study is to find out whether an 8-week digital health promotion program called COBRA is a safe and practical (feasible) option for older adults with cancer/OAC.

Interventions

BEHAVIORALCancer, Older adults, Balance and Resistance Activities

The COBRA intervention is delivered as a web-based application through an iPad configured to allow access only to the study application and Zoom videoconferencing icons during the trial.

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Older Adult Patients with Cancer \- Are within 1 year of completion of primary therapy for cancer OR have a diagnosis of metastatic cancer; 1. For the purpose of this study, primary therapy is defined as treatment of curative intent, first-line or later, from which the individual is advancing to active surveillance or follow-up with or without maintenance therapy. 2. Individuals with metastatic cancer may be included provided they have stable disease or better per most recent restaging exam at time of enrollment. i. Patients with stable metastatic bony disease at most recent restaging exam and a score of 0-2 on the Functional Pain Scale (FPS69; Appendix 18) are eligible. The PI will consult with the Rehab Med co-PI for FPS scores of 3 or greater, by patient request or PI discretion. ii. Patients with symptomatic visceral metastases will be evaluated on a case-by-case basis at time of enrollment. * Are aged 65 years and older, with no upper age limit; * ECOG PS 0-3 or Karnofsky PS greater than or equal to 40; * Can read and speak English; * Self-report access to internet connection sufficient to support videoconferencing. Clinicians * Licensed clinician (MD, RN, APP) with an interest in the care of older adults with cancer.

Exclusion criteria

Older Adult Patients with Cancer * Have any cognitive impairment, neurologic, musculoskeletal, or other comorbid condition (as assessed by their provider) that would prevent the individual from engaging with the digital health coaching program or complete study assessments or engage in progressive intensity levels of physical activity * Have a neurologic, musculoskeletal, or other comorbid condition that would impede their ability to safely engage in progressive intensity levels of physical activity (as assessed by their provider). Patients with metastatic disease and suspected interim progression since last restaging exam will be referred back to their primary oncology care team for evaluation prior to enrollment. * Have activity restrictions post-surgery at the time of enrollment Clinicians No expected exclusions

Design outcomes

Primary

MeasureTime frameDescription
Rate of retention and adherence to the COBRA/Cancer, Older Adults, Balance and Resistance Activities intervention8 weeksRate of retention and adherence to the 8-week intervention to define intervention feasibility

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKristen Fessele, PhD, RN

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 25, 2026